Chunmei D. Yang

79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 53 publications

An interpretable machine learning model integrating [18F]FDG PET/CT radiomics and clinical features for predicting perforation following chemotherapy in gastrointestinal lymphoma: a multicenter study.

An interpretable machine learning model integrating [18F]FDG PET/CT radiomics and clinical features for predicting perforation following chemotherapy in gastrointestinal lymphoma: a multicenter study.

Journal: European journal of nuclear medicine and molecular imaging

Published: February 27, 2026

ZR2-miniCHOP for elderly patients with newly diagnosed diffuse large B-cell lymphoma.

ZR2-miniCHOP for elderly patients with newly diagnosed diffuse large B-cell lymphoma.

Journal: BMC cancer

Published: January 08, 2026

Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.

Liposomal mitoxantrone plus tislelizumab in patients with relapsed or refractory extranodal natural killer/T-cell lymphoma: a phase 1b/2 trial.

Journal: Nature communications

Published: December 24, 2025

Finite-Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia-A Pilot Study.

Finite-Duration Venetoclax/Azacitidine Followed by Umbilical Cord Blood Infusion Improves Outcomes in Frail Elderly Patients With Untreated Acute Myeloid Leukemia-A Pilot Study.

Journal: Cancer medicine

Published: December 13, 2025

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study.

Efficacy of BTK inhibitor combined with rituximab and lenalidomide in newly diagnosed diffuse large B-cell lymphoma: a single-center, retrospective study.

Journal: Annals of hematology

Published: December 02, 2025

IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapy.

IMM2510, a novel anti-PD-L1/VEGF bispecific antibody for cancer immunotherapy.

Journal: Antibody therapeutics

Published: November 14, 2025

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China.

Clinical characteristics and prognostic features of patients with blastoid and pleomorphic variant mantle cell lymphoma: a real-world study in China.

Journal: Annals of hematology

Published: October 27, 2025

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Can baseline red blood cell distribution width predict outcomes in peripheral T-cell lymphoma patients?

Journal: Annals of hematology

Published: October 22, 2025

TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study.

TP53 mutation predict poor prognosis in diffuse large B-cell lymphoma: a single-center study.

Journal: Annals of hematology

Published: October 07, 2025

Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus.

Allogeneic anti-CD19 CAR-T cells induce remission in refractory systemic lupus erythematosus.

Journal: Cell research

Published: March 04, 2025

Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma

Expression and clinical significance of FAT1 gene in pancreatic adenocarcinoma

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: December 02, 2024

Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.

Recombinant human erythropoietin plus all-trans retinoic acid and testosterone undecanoate for the treatment of anemia in patients with lower-risk myelodysplastic syndromes: a multicenter, single-arm, prospective trial.

Journal: Haematologica

Published: November 29, 2024

Showing 1-12 of 53

Last Updated: 09/26/2026